LeMaitre Vascular, Inc. (LMAT) Q1 2019 Earnings Results

Lemaitre Vascular Misses on EPS, Stock Up 1.25%

Lemaitre Vascular's earnings report showed a slight miss on EPS, which may raise concerns among investors. However, the stock reacted positively, increasing by 1.25%, likely due to management's optimistic outlook on future growth and product expansion. Investors may be encouraged by the company's focus on innovation despite the EPS miss.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.17	N/A	-11.84%

Management

Management commentary

Tone: Cautiously Optimistic

Management remains cautiously optimistic about future growth despite missing EPS expectations. They emphasized their commitment to innovation and market expansion.

Management highlighted ongoing efforts to expand product offerings.

They noted challenges in the market but expressed confidence in long-term growth.

Lemaitre Vascular Misses on EPS, Stock Up 1.25%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on EPS, Stock Up 1.25%

Key numbers

Management commentary